ReviewFrontiers in public health2026
Global landscape of cranial prosthesis policies for medical hair loss: a narrative review.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cranial prostheses (CPs) provide indispensable cosmetic and emotional support for individuals with medical hair loss. However, access remains inconsistent due to variable reimbursement policies and unclear classification as medical vs. cosmetic devices. Objective: To characterize global CP coverage frameworks and evaluate how each predominant healthcare system model structures CP access, reimbursement, and eligibility. Methods: We conducted a narrative review of CP policies across representative countries within the four major healthcare system models: Beveridge, Bismarck, National Health Insurance, and out-of-pocket systems. We synthesized data from peer-reviewed literature, government and insurance policy documents, and nonprofit resources to identify common themes in coverage and access. Results: CP coverage varies widely across healthcare systems. Beveridge systems provide formal inclusion but demonstrate regional and administrative variability. Bismarck systems range from standardized, diagnosis-based reimbursement to insurer-dependent models with variable out-of-pocket costs. National Health Insurance systems often lack explicit CP coverage, relying on supplemental insurance and charitable support. The United States exhibits a highly fragmented coverage model, while out-of-pocket systems largely lack formal reimbursement pathways. Across all models, oncology-related hair loss is more consistently covered than non-oncologic etiologies. Limitations: Heterogeneity in available policy data and reliance on publicly available sources may have limited the scope and completeness of our search. Conclusion: CP coverage is globally inconsistent and frequently insufficient, highlighting the need for standardized recognition of CPs as medically necessary devices to improve equitable access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.